Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 89551-89600 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05801614
Normalized Glucose Levels in Type 2 Diabetes With Carbohydrate or Caloric Restriction
NA
Recruiting
286 participants
Started: Feb 28, 2022 · Completed: Feb 28, 2027
1 condition
1 sponsor
1 location
NCT04995588
Systemic Sclerosis and Innate T Cells
NA
Recruiting
240 participants
Started: Feb 28, 2022 · Completed: Jan 28, 2026
1 condition
1 sponsor
1 location
NCT05230524
DIAMOND AF Post-Approval Study
N/A
Recruiting
225 participants
Started: Feb 28, 2022 · Completed: Jan 31, 2029
1 condition
1 sponsor
8 locations
NCT05688774
Study of Progression of Community Acquired Pneumonia in the Hospital in Patients With More Severe Preexisting Diseases and Immunosuppression
N/A
Recruiting
300 participants
Started: Feb 28, 2022 · Completed: Feb 28, 2028
3 conditions
4 sponsors
10 locations
NCT05206708
Assesment of the Efficacy of Personalized Parent-child Psychotherapy in Children Under 3 Years Old
NA
Recruiting
234 participants
Started: Feb 28, 2022 · Completed: Aug 31, 2026
2 conditions
1 sponsor
4 locations
NCT05205291
Molecular Imaging of Inflammation in Parkinson's Disease Using LPS and TSPO-PET/MR
N/A
Recruiting
30 participants
Started: Feb 28, 2022 · Completed: Aug 31, 2026
3 conditions
1 sponsor
1 location
NCT05108441
Ultrasound and MRI Measurement of Quadriceps Femoris Muscle in Critically Ill Children
NA
Recruiting
35 participants
Started: Feb 28, 2022 · Completed: Apr 30, 2026
1 condition
1 sponsor
1 location
NCT04922281
Insertable Cardiac Monitor-Guided Early Intervention to Reduce Atrial Fibrillation Burden Following Catheter Ablation
NA
Active, not recruiting
120 participants
Started: Feb 28, 2022 · Completed: Dec 31, 2026
5 conditions
2 sponsors
1 location
NCT04500756
Limiting AAA With Metformin (LIMIT) Trial
PHASE2
Recruiting
314 participants
Started: Feb 28, 2022 · Completed: Jun 30, 2028
1 condition
4 sponsors
1 location
NCT05205187
Gut Microbiota and Metabonomics
N/A
Recruiting
450 participants
Started: Feb 28, 2022 · Completed: Dec 31, 2025
3 conditions
6 sponsors
6 locations
NCT05044039
Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy
PHASE1
Active, not recruiting
42 participants
Started: Feb 28, 2022 · Completed: May 31, 2030
2 conditions
4 sponsors
1 location
NCT04988555
A Study of DSP-5336 in Relapsed/Refractory AML/ ALL With or Without MLL Rearrangement or NPM1 Mutation
PHASE1/PHASE2
Recruiting
362 participants
Started: Feb 28, 2022 · Completed: Oct 31, 2027
2 conditions
1 sponsor
92 locations
NCT05236686
Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer
NA
Not yet recruiting
69 participants
Started: Feb 28, 2022 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT05205902
TOtal Skin Electron Beam Therapy (Low-dose) for Tumor Clone Eradication in Early-stage Mycosis Fungoides
PHASE3
Not yet recruiting
78 participants
Started: Feb 28, 2022 · Completed: Feb 28, 2031
2 conditions
1 sponsor
0 locations
NCT05465161
STING MARK Universal Fiducial Marker System
NA
Recruiting
100 participants
Started: Feb 28, 2022 · Completed: Nov 1, 2025
1 condition
1 sponsor
1 location
NCT04951050
TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment
NA
Active, not recruiting
200 participants
Started: Feb 28, 2022 · Completed: Dec 31, 2027
2 conditions
1 sponsor
1 location
NCT04332601
Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia
NA
Not yet recruiting
200 participants
Started: Feb 28, 2022 · Completed: Nov 30, 2025
1 condition
3 sponsors
0 locations
NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
PHASE3
Recruiting
640 participants
Started: Feb 28, 2022 · Completed: Nov 27, 2032
1 condition
1 sponsor
93 locations
NCT05170230
The Effect of Intracapsular Injection of Terlipressin Versus Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
NA
Recruiting
99 participants
Started: Feb 27, 2022 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT05894785
External Cephalic Version (ECV) for Twins With Non-vertex Presenting Twin
NA
Recruiting
30 participants
Started: Feb 27, 2022 · Completed: Dec 30, 2025
1 condition
1 sponsor
1 location
NCT05154279
The Effect of Intramyometrial Injection of Terlipressin Versus Intramyometrial Injection of Carbitocin on Hemoglobin and Blood Loss During Laparoscopic Myomectomy Operations
NA
Recruiting
99 participants
Started: Feb 27, 2022 · Completed: Mar 30, 2026
1 condition
1 sponsor
2 locations
NCT05026749
Azithromycin Treatment for Respiratory Syncytial Virus-induced Respiratory Failure in Children
PHASE3
Recruiting
370 participants
Started: Feb 27, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
10 locations
NCT05257018
R-CDOP Combined With Intrathecal Methotrexate for DLBCL Patients With High-risk of CNS Relapse
PHASE2
Recruiting
83 participants
Started: Feb 26, 2022 · Completed: Jan 30, 2028
1 condition
1 sponsor
2 locations
NCT05279755
A Study to Evaluate the Safety and Pharmacokinetics of Single and Multiple Doses of Prosetin in Healthy Volunteers and Participants With ALS
PHASE1
Recruiting
72 participants
Started: Feb 26, 2022 · Completed: Oct 31, 2026
1 condition
2 sponsors
4 locations
NCT04647240
Dermacyte® Amniotic Wound Care Liquid for the Treatment of Non-Healing Venous Stasis Ulcers
PHASE2
Recruiting
50 participants
Started: Feb 26, 2022 · Completed: Oct 15, 2025
2 conditions
2 sponsors
9 locations
NCT04897347
Robotic TruST-Postural Intervention for Children With Cerebral Palsy
NA
Recruiting
82 participants
Started: Feb 26, 2022 · Completed: Jun 30, 2027
1 condition
2 sponsors
2 locations
NCT04634266
TRICuspid Intervention in Heart Failure Trial
NA
Recruiting
360 participants
Started: Feb 25, 2022 · Completed: Mar 1, 2027
1 condition
6 sponsors
23 locations
NCT05167448
A Study of ES104 in Patients With Metastatic Colorectal Cancer
PHASE1/PHASE2
Active, not recruiting
58 participants
Started: Feb 25, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT06030544
Oleanolic Acid as Therapeutic Adjuvant for Type 2 Diabetes Mellitus (OLTRAD STUDY)
PHASE2
Active, not recruiting
100 participants
Started: Feb 25, 2022 · Completed: Jun 30, 2025
2 conditions
3 sponsors
1 location
NCT05024552
Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML
PHASE1
Recruiting
22 participants
Started: Feb 25, 2022 · Completed: Mar 31, 2027
1 condition
2 sponsors
1 location
NCT05185843
A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen
PHASE3
Active, not recruiting
24 participants
Started: Feb 25, 2022 · Completed: Jun 30, 2027
1 condition
1 sponsor
11 locations
NCT05197608
At-risk and vulNerable Individuals To Infection With COVID-19 and ProActive inTervention With intEgrated Health and Social Care
NA
Recruiting
180 participants
Started: Feb 25, 2022 · Completed: Mar 31, 2024
3 conditions
7 sponsors
1 location
NCT05084430
Study of Pembrolizumab and M032 (NSC 733972)
PHASE1/PHASE2
Recruiting
28 participants
Started: Feb 25, 2022 · Completed: Mar 1, 2028
3 conditions
1 sponsor
1 location
NCT05868434
MPFLR With Fascia Lata Allograft, Based on Isometry Assessment + Elmslie-Trillat TTO
NA
Recruiting
15 participants
Started: Feb 25, 2022 · Completed: Dec 31, 2026
2 conditions
1 sponsor
1 location
NCT05214547
Effectiveness of Focal Vibration in Shoulder Pathology
NA
Recruiting
20 participants
Started: Feb 25, 2022 · Completed: Jun 25, 2024
2 conditions
1 sponsor
1 location
NCT05172752
A University-Community Partnership to Reduce Exposure to Disinfection Byproducts In Appalachia
NA
Recruiting
200 participants
Started: Feb 25, 2022 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT04888988
Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy
NA
Active, not recruiting
133 participants
Started: Feb 25, 2022 · Completed: Nov 7, 2025
3 conditions
2 sponsors
93 locations
NCT05223530
Prenatal Programming of Childhood Obesity and Cardio Metabolic Disorders
N/A
Recruiting
750 participants
Started: Feb 25, 2022 · Completed: Dec 31, 2026
2 conditions
4 sponsors
1 location
NCT04992780
Comparing Hypo-fractionated Intensity- Modulated Radiation Therapy to Standard- Fractionated IMRT Along With Chemotherapy and Immunotherapy for Non-Small Cell Lung Cancer
PHASE2
Recruiting
50 participants
Started: Feb 25, 2022 · Completed: Nov 30, 2026
1 condition
1 sponsor
6 locations
NCT05222802
A Study to Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)
PHASE1
Active, not recruiting
52 participants
Started: Feb 25, 2022 · Completed: Sep 30, 2025
1 condition
2 sponsors
8 locations
NCT05283174
The Association Between Non-vitamin K Antagonist Oral Anticoagulant Therapy and Acute Stroke Severity and Post Stroke Short-term and Long-term Outcomes.
N/A
Recruiting
500 participants
Started: Feb 25, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05367232
A Study of ICP-033 in Patients With Advanced Solid Tumors
PHASE1
Recruiting
60 participants
Started: Feb 25, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05231408
Effects of Aerobic Exercise in Patients With Post COVID-19
NA
Recruiting
30 participants
Started: Feb 25, 2022 · Completed: Jan 15, 2025
1 condition
1 sponsor
1 location
NCT05221281
Implementing a Multimodal RCT Intervention to Improve the Transition of Patients With Crohn's Disease From Pediatric to Adult Care
NA
Active, not recruiting
90 participants
Started: Feb 25, 2022 · Completed: Dec 31, 2025
6 conditions
5 sponsors
3 locations
NCT04844528
Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia (CLL) With History of Non-melanoma Skin Cancers (NMSC)
PHASE2
Recruiting
86 participants
Started: Feb 25, 2022 · Completed: Aug 31, 2028
2 conditions
2 sponsors
1 location
NCT05091645
Translation and Cultural Adaptation of the Groningen Frailty Indicator (GFI) in Patients With Hip Fracture
N/A
Recruiting
89 participants
Started: Feb 25, 2022 · Completed: Jul 30, 2024
2 conditions
1 sponsor
1 location
NCT05223231
Evaluation of LBL-019 Monotherapy or Combined With Anti-PD-1 Antibody in the Treatment of Advanced Malignant Tumors
PHASE1/PHASE2
Recruiting
486 participants
Started: Feb 24, 2022 · Completed: Oct 22, 2025
1 condition
1 sponsor
6 locations
NCT05308316
Sugars in Cigarettes
NA
Active, not recruiting
38 participants
Started: Feb 24, 2022 · Completed: May 31, 2026
1 condition
1 sponsor
1 location
NCT05064319
Gabapentin for Restoring GABA/Glutamate Homeostasis in Co-occurring Bipolar and Cannabis Use Disorders
PHASE2
Recruiting
68 participants
Started: Feb 24, 2022 · Completed: Jun 30, 2026
8 conditions
2 sponsors
1 location
NCT05279313
A Trial of Centanafadine Long-term Safety in Children and Adolescents With Attention-deficit/Hyperactivity Disorder (ADHD)
PHASE3
Active, not recruiting
680 participants
Started: Feb 24, 2022 · Completed: Mar 25, 2026
1 condition
1 sponsor
86 locations
Previous
1
More pages
1789
1790
1791
1792
1793
1794
1795
More pages
2369
Next